New option for trial recruitment

Digital medication management operator MedAdvisor has launched into clinical trial recruitment with CEO Robert Read promising a "win for patients and a win for innovative pharmaceutical and biotech companies".

MedAdvisor markets a medication adherence software platform, which it claims "approves adherence to common medications by approximately 20 per cent". It has existing business relationships in branded and generic pharma and with major wholesaler EBOS.

In a statement to the ASX issued on Monday, the company said it had already completed four "small scale trials" and would be actively offering the new service to existing and new clients.